Zobrazeno 1 - 5
of 5
pro vyhledávání: '"ME Martinez-Nuñez"'
Autor:
ME Martinez Nuñez, N Herranz Muñoz, JB Cacho Calvo, FJ Esteban Fernandez, F Ferrere Gonzalez, A Gonzalez Torralba, D Molina Arana, G Perez Caballero, AM Rodriguez Benavente, T Molina Garcia
Publikováno v:
Section 4: Clinical pharmacy services.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1bbb32757a6c5505d2d2807d928af671
https://doi.org/10.1136/ejhpharm-2023-eahp.168
https://doi.org/10.1136/ejhpharm-2023-eahp.168
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance According to the study by Bury D et al,1 vancomycin dosage should be 25% higher than standard dosages in neutropenic patients due to increased clearance of vancomycin in this population. Renal hyperfiltration is considered a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::033e671b885823e474a274ddaac4ef9f
https://doi.org/10.1136/ejhpharm-2020-eahpconf.136
https://doi.org/10.1136/ejhpharm-2020-eahpconf.136
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background The incidence of infections due to extensively drug-resistant (XDR) and pandrug-resistant (PDR) strains of Pseudomonas aeruginosa (PSA)is increasing, mainly due to the overuse of antibiotics. Purpose The aim of this study was to identify a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e4c30bb16dda885066aa92d518f1bd5
https://doi.org/10.1136/ejhpharm-2019-eahpconf.192
https://doi.org/10.1136/ejhpharm-2019-eahpconf.192
Autor:
R Vazquez-Sanchez, J Sánchez-Rubio-Ferrandez, A Onteniente-González, A Liras-Medina, B Reques, ME Martinez-Nuñez, T Molina
Publikováno v:
European Journal of Hospital Pharmacy. 23:A191.3-A192
Background Initial intravenous dosing with vancomycin should be based on actual body weight (ABW) and subsequent dose titration based on renal function and serum trough concentrations. The manufacturer´s labelling recommends 500 mg/6 h or 1000 mg/12
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::803f4e07bbc2c308c957a8249493b50d
https://doi.org/10.1136/ejhpharm-2016-000875.433
https://doi.org/10.1136/ejhpharm-2016-000875.433
Autor:
A Liras-Medina, R Vazquez-Sanchez, A Onteniente-González, ME Martinez-Nuñez, T Molina, C Martin-Blas, M Achaques-Rodriguez, J Sanchez-Rubio
Publikováno v:
European Journal of Hospital Pharmacy. 23:A234.2-A234
Background The objective of preoperative antibiotic prophylaxis (PAP) is to reduce the incidence of postoperative wound infection. In our centre, the pharmacy service is actively involved in the PAP antibiotic aseptic compounding in the centralised i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::937ed85ac738b4b51501e1d8f51cb003
https://doi.org/10.1136/ejhpharm-2016-000875.531
https://doi.org/10.1136/ejhpharm-2016-000875.531